Feed NBRVF
NB

Nabriva Therapeutics plc

NBRVF · OTC

$0.00 +0.00% (+$0.00)
Market Cap $323.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.00x
P/B 0.00x
P/E N/A
Growth
78 /100
Growing
Rev. growth 66.35%
Book val. growth 56.95%
EPS growth N/A
Profitability
6 /100
Weak
Gross margin 19.87%
Net margin 160.33%
FCF margin 103.52%
Quality
20 /100
Poor
ROIC 634.43%
ROA 180.03%
Asset turnover 1.12x
Debt
51 /100
Moderate
Debt/Equity 1.59x
Current ratio 1.13x
Net debt/EBITDA 0.13x
Stability
35 /100
Moderate
Beta -0.68x
Rev. volatility 258.14%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o NBRVF
Online

Sector

Healthcare

Industry

Biotechnology

CEO

H. Michael Hogan

Employees

39

Headquarters

Dublin

Prihajajoči dogodki

13 NOV.

Earnings

Upcoming earnings report

53d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.